KR850006405A - 메플로킨 항말라리아 화합물의 키닌산염 - Google Patents

메플로킨 항말라리아 화합물의 키닌산염 Download PDF

Info

Publication number
KR850006405A
KR850006405A KR1019850001214A KR850001214A KR850006405A KR 850006405 A KR850006405 A KR 850006405A KR 1019850001214 A KR1019850001214 A KR 1019850001214A KR 850001214 A KR850001214 A KR 850001214A KR 850006405 A KR850006405 A KR 850006405A
Authority
KR
South Korea
Prior art keywords
compound
formula
kinate
product
quinic acid
Prior art date
Application number
KR1019850001214A
Other languages
English (en)
Inventor
프랑소와 로시뇰 쟝
Original Assignee
리챠드 도미니크 포기오
스미스 클라인 베크만 코퍼레이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리챠드 도미니크 포기오, 스미스 클라인 베크만 코퍼레이션 filed Critical 리챠드 도미니크 포기오
Publication of KR850006405A publication Critical patent/KR850006405A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/02Saturated compounds containing hydroxy or O-metal groups
    • C07C62/04Saturated compounds containing hydroxy or O-metal groups with a six-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

메플로킨 항말라리아 화합물의 키니산염
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 불활성 용매중에서 식(Ⅱ)의 화합물과 키니산을 반응시켜 구조식(Ⅰ)롤 대표하는 화합물을 제조하는 방법.
    여기에서 n은 1 또는 2이다.
  2. 약 1.0몰의 키닌산과 1.0몰의 식(Ⅱ)의 화합물을 사용하는 청구범위 제1항의 제조방법.
  3. 약 2.0몰의 키닌산과 1.0몰의 식(Ⅱ)의 화합물을 채택 사용하는 청구범위 제1항의 제조방법.
  4. 생성물이 α-2-피페리디닐-2,8-비스(트리플루오로메틸)-4-키놀린메탄올 키닌산염 또는 α-2-피페리디닐-2,8-비스(트리플루오로메틸)-4-키놀린 메탄올 2키닌산염이며, 생성물이 고체 미립자 옆으로 분리되는 청구범위 제1 내지 제3항의 어느 하나인 제조방법.
  5. 청구범위 제1항 화합물의 비독성 항말라리아 용량과 그 약제허용 담체를 함유라는 말라리아 치료용약제 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850001214A 1984-02-27 1985-02-27 메플로킨 항말라리아 화합물의 키닌산염 KR850006405A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/584,183 US4521424A (en) 1984-02-27 1984-02-27 Quinate salts of the antimalarial compound mefloquine
US584,183 1984-02-27

Publications (1)

Publication Number Publication Date
KR850006405A true KR850006405A (ko) 1985-10-05

Family

ID=24336239

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850001214A KR850006405A (ko) 1984-02-27 1985-02-27 메플로킨 항말라리아 화합물의 키닌산염

Country Status (15)

Country Link
US (1) US4521424A (ko)
EP (1) EP0154491B1 (ko)
JP (1) JPS60202880A (ko)
KR (1) KR850006405A (ko)
AT (1) ATE51227T1 (ko)
AU (1) AU577570B2 (ko)
DE (1) DE3576687D1 (ko)
DK (1) DK84785A (ko)
ES (1) ES540693A0 (ko)
GR (1) GR850484B (ko)
JO (1) JO1358B1 (ko)
PH (1) PH22441A (ko)
PT (1) PT80013B (ko)
ZA (1) ZA851429B (ko)
ZW (1) ZW2885A1 (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748333A1 (de) * 1977-10-28 1979-05-03 Hoechst Ag Mittel gegen malaria

Also Published As

Publication number Publication date
PT80013B (en) 1987-01-14
AU3921285A (en) 1985-09-05
EP0154491A2 (en) 1985-09-11
US4521424A (en) 1985-06-04
JO1358B1 (en) 1986-11-30
PH22441A (en) 1988-09-12
DK84785D0 (da) 1985-02-25
DK84785A (da) 1985-08-28
EP0154491A3 (en) 1986-07-30
DE3576687D1 (de) 1990-04-26
PT80013A (en) 1985-03-01
EP0154491B1 (en) 1990-03-21
AU577570B2 (en) 1988-09-29
GR850484B (ko) 1985-06-26
ZA851429B (en) 1985-10-30
ATE51227T1 (de) 1990-04-15
JPS60202880A (ja) 1985-10-14
ES8601967A1 (es) 1985-11-16
ES540693A0 (es) 1985-11-16
ZW2885A1 (en) 1985-05-22

Similar Documents

Publication Publication Date Title
KR840000528A (ko) 비스-트리아졸 유도체의 제조방법
KR880006206A (ko) 퀴나졸리논 유도체 및 이의 제조방법
KR880001625A (ko) 탁솔 유도체, 그 제법 및 그들을 함유한 약제학적 조성물
ATE63124T1 (de) Prodrugverbindungen, verfahren zu deren herstellung und diese enthaltende zubereitungen mit verzoegerter freisetzung.
KR870008846A (ko) 8-위치 치환된 퀴놀론카복실산 유도체 및 그의 제조방법
FR2374307A1 (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
KR890011838A (ko) 16-데하이드로 비타민d₃-유도체
DE3676179D1 (de) N-enthaltende heterozyklische verbindungen, verfahren zu deren herstellung und diese enthaltende arzneimittel.
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
KR910006309A (ko) 인지질 및 인지질 유도체를 유효 성분으로 하는 항비루스성 약제
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
KR860008111A (ko) 인딘과 나프탈렌 유도체의 제조방법
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
KR910014380A (ko) 이미자조피리다진 화합물, 그의 제법 및 용도
FR2415636A1 (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
KR960031442A (ko) 페닐시클로헥실카르복스아미드의 용도
KR880011122A (ko) 4-티오퀴나졸린 유도체, 이의 제조방법 및 약제학적 조성물
KR920021530A (ko) 2-아미노-5-시아노-1,4-디히드로피리딘, 그의 제조방법 및 약제로서의 그의 용도
KR900003179A (ko) 벤조디아제핀 화합물 및 약제로서의 이의 용도
KR850006405A (ko) 메플로킨 항말라리아 화합물의 키닌산염
FR2384771A1 (fr) Derives de quinazoline utiles comme medicament
ATE53030T1 (de) Verbindung mit entzuendungshemmender wirkung, verfahren zu ihrer herstellung und pharmazeutische praeparate die sie enthalten.
KR840006810A (ko) 세팔로스포린 에스테르의 제조방법
KR870006040A (ko) 치환된 4-플루오로-이소인돌린, 그의 제조방법과 용도 및 이들을 함유하는 제제

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid